Navigation Links
Arius Features Preclinical Data on Antibody Candidates at Two Conferences
Date:9/7/2007

TORONTO, Sept. 7 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that it will deliver poster presentations at two scientific conferences reporting preclinical data for two of its anti-cancer antibody drug candidates.

At the 2007 Breast Cancer Symposium in San Francisco on September 7-8, Arius will report recent results of its antibody candidate that targets CD44, an antigen implicated as a cancer stem cell marker. The poster outlines recent results for this antibody which demonstrate that it is a potent therapeutic in breast cancer models both in vivo and in vitro. The poster also highlights the prevalence of the epitope targeted by Arius' antibody in breast cancer patients.

The poster presentation is entitled "Development of a potent therapeutic monoclonal antibody targeting CD44 in breast cancer" and will be presented at General Poster Session D, 11:45-12:45 pm on Saturday, September 8th at the San Francisco Marriott.

At the XIth European Meeting on Complement in Human Disease held in Cardiff, Wales on September 8-11, Arius will report results demonstrating that its monoclonal antibody targeting CD59, a cell surface molecule involved in regulating cell lysis mediated by the complement system, is a potent therapeutic in various in vivo cancer models. Arius has demonstrated that its antibody is highly potent at low doses and its efficacy in certain models compares favorably to Taxotere.

The poster presentation is entitled "AR36A36.11.1, a monoclonal antibody targeting CD59, enhances complement activity and exhibits potent in vivo efficacy in multiple human cancer models" and will be presented at Poster Session 1: Inflammatory diseases, therapeutics and diagnostics, 4:00-6:00 pm on Sunday, September 9th at Cardiff City Hall, Cathay's Park.

About ARIUS

ARIUS is a biotechnology company discovering and developing
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Streptococcus salivarius
2. Streptococcus salivarius
3. New Temperature Cycler Features Interchangeable Blocks
4. Yeast Protein Production System Features High Yields and One-Step Purification
5. Sometimes, features can make a company
6. Berbee adds features to VoIP broadcast system
7. PKWare launches new enterprise product line, adds new features to PKZip
8. Detection of antibody-stained cell surface and intracellular protein targets with the Agilent 2100 bioanalyzer
9. Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System
10. Mobile Phase Optimization for the Analysis of an Antibody-Based Fusion Protein and Aggregates using a TSKgel Super SW3000 Size-Exclusion Column
11. What citizens dont ask political candidates

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...v. 24 Sigma-Aldrich Corp... NASDAQ OMX conference on Tuesday, December 1st at... parties may listen via live audio broadcast over ...g m a a ldrich.com/ . Users can click the "W...Sigma-Aldrich: Sigma-Aldrich is a leading Life S...
(Date:11/24/2009)... REYKJAVIK, Iceland, November 24 /PRNewswire-First...ay announced the approval of all of its,"first day...trict of Delaware,(the "Bankruptcy Court"). deCODE...nder Chapter 11 of the United States Bankruptcy Co...s issued by the Bankruptcy Court allow the company...
(Date:11/24/2009)...alif., Nov. 24 NeurogesX...ny focused on developing and commercializing novel...nthony DiTonno, President and Chief Executive Offi...per Jaffray Health Care Conference, to be held Dec...w York, New York. ,, Mr. DiTonno and Stephen G...
(Date:11/24/2009)... Blue Marble Energy Corp. announce...elopment Authority (OPDA) were recently awarded $2...Revitalization Board (CERB) in a private/public pa... biochemical biorefinery in Lincoln County, WA. ...e development of our biorefinery and bring over 70...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...er 15 Agendia BV, world leader in the,rapidly evo...day that it,has acquired the rights to the discove...ently-used breast cancer drug Herceptin(R), which ...l "Cancer Cell". The antibody drug Herceptin(R) t...about one in four breast cancers and the HER2 prot...
...ct. 15 The U.S. Food and Drug,Administration (FDA...n) as,a new treatment for complicated intra-abdomi...uding pyelonephritis. DORIBAX has demonstrated,act... Gram-negative(2),bacteria -- including Pseudomona... belongs to a class of antibacterial agents called...
...15 /PRNewswire-FirstCall/ - Neptune Technologies &....V.NTB), is pleased to,announce the appointment of...isory Board"), comprised of 5 renowned scientists.... experience of the new,members of the Advisory Boa...ntifically driven growth. Neptune feels privileged...
Other Biology Technology:Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test 2FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections 2FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections 3FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections 4FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections 5Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board 2Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board 3
(Date:11/26/2009)...t Staphylococcus Aureus ) and other drug-resistan...ure plasma prototype devices have been developed t...al cocktails. , Two prototype devices have been ...hy skin (e.g. hands and feet) in hospitals and pub...; and another to shoot bacteria-killing agents int...
(Date:11/25/2009)...of the Cell Death Research Laboratory in the Unive...warded the prestigious Johnson & Johnson Focused F...of brain cell damage in Parkinson,s disease. The a...support of innovation and excellence in science, w...lier this month at an event at the Hyatt Regency H...
(Date:11/24/2009)...has been prescribed by traditional healers in Braz... stomach pain to fever and flu. , Now for the fir...been able to scientifically prove the pain relievi... as Brazilian mint. , Testing this ancient South ...Graciela Rocha was able to show that when prepared...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Pharmaxis Announces Placement of 2447 Million and Share Purchase Plan 12459 1Pharmaxis Announces Placement of 2447 Million and Share Purchase Plan 12459 2Orlando Dermatology Aesthetic 26 Clinical 28ODAC 29 Conference Announces Its 2010 Event 47854 1Orlando Dermatology Aesthetic 26 Clinical 28ODAC 29 Conference Announces Its 2010 Event 47854 2Pausing Hormone Therapy Doesnt Cut Mammogram Recalls 47850 1Pausing Hormone Therapy Doesnt Cut Mammogram Recalls 47850 2
...m better understand the diseases their children co...ring practical advice for preventing infections in...f Your Kids: The Complete Guide to Protecting (wit...released this week by ASM Press, is the inside sou... to health foods and home remedies. Written by in...
...ice for all types of gasoline is holding steady ar...the pump might be short-lived as research from the...ggest hurdles to the wide-scale production of fuel...ant professor of chemical and biomolecular enginee...d to make a fuel cell more efficient and less expe...
...eveloped a cancer fighting technology which uses U...ally attack tumours. , Therapeutic antibodies ha...ial but getting them to efficiently target tumour ...ofessor Colin Self and Dr Stephen Thompson from Ne...loak antibodies which can then be activated by UV-...
Other Biology News:Handbook helps parents deal with childhood infections 2Fuel cells gearing up to power auto industry 2Fuel cells gearing up to power auto industry 3UV light improving chances of fighting cancer 2
...adiochemical Purity is >95%NEN Radiolabeled Ligand...ed by the continual availability of new radiolabel...ies. PerkinElmer offers a wide range of products a...ry, including over 400 state-of-the-art radioligan...
...The benchmark for analytical performance , When...tical,performance, the Varian 810-MS delivers.,...ue* collisional interface/extraction optics minimi...race level,quantification. , Optimized sample...
...OTE: 0.9 ml per liter of urine will give a positiv...ck. ,Certification: The Donors are of US origin a...bsAg, HCV, HIV-1 & 2, Syphilis and HIV-1 Antigen b... SOLD FOR IN-VITRO DIAGNOSTIC USE ONLY IN MANUFACT...
...he LUMIstar OPTIMA is a fully automated microplate...st possible range of applications based on lumines...alactosidase, gene activities with luminescence su...) Luminescent Immunoassays Cell-based assays (cy...
Biology Products: